- Home
- STRO vs ALTO Comparison
STRO vs ALTO Comparison
Compare STRO & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STRO | ALTO |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | United States | United States |
| Employees | 133 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.8M | 420.7M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | STRO | ALTO |
|---|---|---|
| Price | $26.85 | $5.61 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $31.33 | N/A |
| AVG Volume (30 Days) | 303.0K | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 119.51 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $917,927,000.00 |
| Revenue This Year | N/A | $6.66 |
| Revenue Next Year | N/A | $0.43 |
| P/E Ratio | ★ N/A | $113.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.67 | $0.92 |
| 52 Week High | $43.85 | $6.00 |
Technical Indicators
Market Signals| Indicator | STRO | ALTO |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 58.06 |
| Support Level | $23.53 | $4.27 |
| Resistance Level | $27.96 | $6.00 |
| Average True Range (ATR) | 2.87 | 0.38 |
| MACD | -0.33 | 0.03 |
| Stochastic Oscillator | 40.44 | 76.37 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.